Exactech has launched its new modular device, Equinoxe Humeral Reconstruction Prosthesis, for clinical use in Europe.
The humeral reconstruction prosthesis is developed for patient-specific sizing and intraoperative flexibility.
The shoulder implant provides a stable solution for complex and challenging cases with significant humeral bone loss.
Equinoxe is claimed to be the first modular device in the US that is also designed for reconstruction following tumour resections.
It also addresses straightforward cases and offers a number of options for achieving joint stability, regardless of proximal humeral resection length.
Initially introduced in the US in 2015, the device is used in anatomic oncology procedures and primary or revision arthroplasty procedures.
The company stated that the humeral reconstruction prosthesis has been used to treat more than 1,500 patients and is now available in Germany, Italy, Spain, France and the UK.
Exactech Extremities senior vice-president Chris Roche said: “The Humeral Reconstruction Prosthesis was the first reverse total shoulder arthroplasty (TSA) device cleared for use in the US for significant resection of the proximal humerus.
“It incorporates many unique design features intended to mitigate complications associated with these challenging cases, including collars available in 17 different sizes to achieve rotational stability and fixation for the full range of bone sizes.”
Equinoxe comes with a platform stem, several soft tissue attachments and multiple modular segments that enable reconstruction between 50mm-212.5mm and 60mm-222.5mm.
It also offers biomechanical advantages, such as rotational stability, due to its unique plasma/hydroxyapatite (HA) coated collars, which provide fixation and optimal fit.